IDXX Stock IDEXX Laboratories (IDXX, $752.14) was a top quarterly gainer, rising +17.21%

GET DAILY SIGNALS

Get AI intraday signals

IDXX - IDEXX Laboratories

Loading...

Price: $752.14

Daily change: +$26.23 (+3.61%)

Daily volume: 1.3M

3-month price change: +$110.42 (+17.21%)

Capitalization: $60.1B

Industry: Medical Specialties

IDEXX Laboratories (IDXX, $752.14) was one of top quarterly gainers, jumping +1 to $752.14 per share. A.I.dvisor analyzed 83 stocks in the Medical Specialties Industry over the last three months, and discovered that of them (8) charted an Uptrend while of them (1) trended down.

IDXX's Stochastic Oscillator stoops into oversold zone

The Stochastic Oscillator for IDXX moved into oversold territory on December 26, 2025. Be on the watch for the price uptrend or consolidation in the future. At that time, consider buying the stock or exploring call options.

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IDXX advanced for three days, in of 309 cases, the price rose further within the following month. The odds of a continued upward trend are .

IDXX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 211 cases where IDXX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for IDXX moved out of overbought territory on November 26, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 26 similar instances where the indicator moved out of overbought territory. In of the 26 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on December 08, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on IDXX as a result. In of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for IDXX turned negative on December 03, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at .

IDXX moved below its 50-day moving average on December 23, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IDXX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. IDXX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock slightly better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (35.211) is normal, around the industry mean (12.326). P/E Ratio (54.598) is within average values for comparable stocks, (130.839). IDXX's Projected Growth (PEG Ratio) (4.066) is slightly higher than the industry average of (1.860). IDXX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.017). P/S Ratio (13.477) is also within normal values, averaging (11.828).